Rab18 facilitates dengue virus infection by targeting fatty acid synthase to sites of viral replication

Journal of Virology

Volumn 88, Issue 12, 2014, Pages 6793-6804

  Tang, Wei Chun ^a,b   Lin, Ren Jye ^c,d   Liao, Ching Len ^a   Lin, Yi Ling ^a,b,e  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET; FATTY ACID SYNTHASE; NONSTRUCTURAL PROTEIN 3; RAB PROTEIN; RAB18 PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 2; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; LIFE CYCLE; LIPOGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

DENGUE; DENGUE VIRUS; ENDOPLASMIC RETICULUM; FATTY ACID SYNTHASES; HUMANS; PROTEIN BINDING; PROTEIN TRANSPORT; RAB GTP-BINDING PROTEINS; RNA HELICASES; SERINE ENDOPEPTIDASES; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84901296162     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00045-14     Document Type: Article

References (44)

1. Halstead SB. 2007. Dengue. Lancet 370:1644-1652. http://dx.doi.org/10.1016/S0140-6736(07)61687-0.
2. Fischl W, Bartenschlager R. 2011. Exploitation of cellular pathways by Dengue virus. Curr. Opin. Microbiol. 14:470-475. http://dx.doi.org/10.1016/j.mib.2011.07.012.
3. Nagy PD, Pogany J. 2012. The dependence of viral RNA replication on co-opted host factors. Nat. Rev. Microbiol. 10:137-149. http://dx.doi.org/10.1038/nrmicro2692.
4. Welsch S, Miller S, Romero-Brey I, Merz A, Bleck CK, Walther P, Fuller SD, Antony C, Krijnse-Locker J, Bartenschlager R. 2009. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 5:365-375. http://dx.doi.org/10.1016/j.chom.2009.03.007.
5. Perera R, Riley C, Isaac G, Hopf-Jannasch AS, Moore RJ, Weitz KW, Pasa-Tolic L, Metz TO, Adamec J, Kuhn RJ. 2012. Dengue virus infection perturbs lipid homeostasis in infected mosquito cells. PLoS Pathog. 8:e1002584. http://dx.doi.org/10.1371/journal.ppat.1002584.
6. Heaton NS, Perera R, Berger KL, Khadka S, Lacount DJ, Kuhn RJ, Randall G. 2010. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc. Natl. Acad. Sci. U. S. A. 107:17345-17350. http://dx.doi.org/10.1073/pnas.1010811107.
7. Menendez JA, Lupu R. 2007. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7:763-777. http://dx.doi.org/10.1038/nrc2222.
8. Samsa MM, Mondotte JA, Iglesias NG, Assuncao-Miranda I, Barbosa-Lima G, Da Poian AT, Bozza PT, Gamarnik AV. 2009. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 5:e1000632. http://dx.doi.org/10.1371/journal.ppat.1000632.
9. Heaton NS, Randall G. 2010. Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8:422-432. http://dx.doi.org/10.1016/j.chom.2010.10.006.
10. Stenmark H. 2009. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 10:513-525. http://dx.doi.org/10.1038/nrm2728.
11. Saka HA, Valdivia R. 2012. Emerging roles for lipid droplets in immunity and host-pathogen interactions. Annu. Rev. Cell Dev. Biol. 28:411-437. http://dx.doi.org/10.1146/annurev-cellbio-092910-153958.
12. Farese RV, Jr, Walther TC. 2009. Lipid droplets finally get a little R-E-SP-E-C-T. Cell 139:855-860. http://dx.doi.org/10.1016/j.cell.2009.11.005.
13. Krahmer N, Guo Y, Farese RV, Jr, Walther TC. 2009. SnapShot: lipid droplets. Cell 139:1024-1024.e1021. http://dx.doi.org/10.1016/j.cell.2009.11.023.
14. Martin S, Driessen K, Nixon SJ, Zerial M, Parton RG. 2005. Regulated localization of Rab18 to lipid droplets: effects of lipolytic stimulation and inhibition of lipid droplet catabolism. J. Biol. Chem. 280:42325-42335. http://dx.doi.org/10.1074/jbc. M506651200.
15. Ozeki S, Cheng J, Tauchi-Sato K, Hatano N, Taniguchi H, Fujimoto T. 2005. Rab18 localizes to lipid droplets and induces their close apposition to the endoplasmic reticulum-derived membrane. J. Cell Sci. 118:2601-2611. http://dx.doi.org/10.1242/jcs.02401.
16. Pulido MR, Diaz-Ruiz A, Jimenez-Gomez Y, Garcia-Navarro S, Gracia-Navarro F, Tinahones F, Lopez-Miranda J, Fruhbeck G, Vazquez-Martinez R, Malagon MM. 2011. Rab18 dynamics in adipocytes in relation to lipogenesis, lipolysis and obesity. PLoS One 6:e22931. http://dx.doi.org/10.1371/journal.pone.0022931.
17. Vazquez-Martinez R, Cruz-Garcia D, Duran-Prado M, Peinado JR, Castano JP, Malagon MM. 2007. Rab18 inhibits secretory activity in neuroendocrine cells by interacting with secretory granules. Traffic 8:867-882. http://dx.doi.org/10.1111/j.1600-0854.2007.00570.x.
18. Dejgaard SY, Murshid A, Erman A, Kizilay O, Verbich D, Lodge R, Dejgaard K, Ly-Hartig TB, Pepperkok R, Simpson JC, Presley JF. 2008. Rab18 and Rab43 have key roles in ER-Golgi trafficking. J. Cell Sci. 121: 2768-2781. http://dx.doi.org/10.1242/jcs.021808.
19. Vazquez-Martinez R, Malagon MM. 2011. Rab proteins and the secretory pathway: the case of rab18 in neuroendocrine cells. Front. Endocrinol. (Lausanne) 2:1. http://dx.doi.org/10.3389/fendo.2011.00001.
20. Makarova O, Kamberov E, Margolis B. 2000. Generation of deletion and point mutations with one primer in a single cloning step. Biotechniques 29:970-972. http://www.biotechniques.com/multimedia/archive/00010/00295bm08_10062a.pdf.
21. Lin RJ, Yu HP, Chang BL, Tang WC, Liao CL, Lin YL. 2009. Distinct antiviral roles for human 2=,5=-oligoadenylate synthetase family members against dengue virus infection. J. Immunol. 183:8035-8043. http://dx.doi.org/10.4049/jimmunol.0902728.
22. Yu CY, Hsu YW, Liao CL, Lin YL. 2006. Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J. Virol. 80:11868-11880. http://dx.doi.org/10.1128/JVI.00879-06.
23. Lin YL, Liao CL, Chen LK, Yeh CT, Liu CI, Ma SH, Huang YY, Huang YL, Kao CL, King CC. 1998. Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J. Virol. 72:9729-9737.
24. Yu CY, Chang TH, Liang JJ, Chiang RL, Lee YL, Liao CL, Lin YL. 2012. Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog. 8:e1002780. http://dx.doi.org/10.1371/journal.ppat.1002780.
25. Wang WK, Sung TL, Tsai YC, Kao CL, Chang SM, King CC. 2002. Detection of dengue virus replication in peripheral blood mononuclear cells from dengue virus type 2-infected patients by a reverse transcriptionreal-time PCR assay. J. Clin. Microbiol. 40:4472-4478. http://dx.doi.org/10.1128/JCM.40.12.4472-4478.2002.
26. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY. 2004. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22:1567-1572. http://dx.doi.org/10.1038/nbt1037.
27. Krishnan MN, Sukumaran B, Pal U, Agaisse H, Murray JL, Hodge TW, Fikrig E. 2007. Rab 5 is required for the cellular entry of dengue and West Nile viruses. J. Virol. 81:4881-4885. http://dx.doi.org/10.1128/JVI.02210-06.
28. van der Schaar HM, Rust MJ, Chen C, van der Ende-Metselaar H, Wilschut J, Zhuang X, Smit JM. 2008. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 4:e1000244. http://dx.doi.org/10.1371/journal.ppat.1000244.
29. Acosta EG, Castilla V, Damonte EB. 2012. Differential requirements in endocytic trafficking for penetration of dengue virus. PLoS One 7:e44835. http://dx.doi.org/10.1371/journal.pone.0044835.
30. Xu XF, Chen ZT, Zhang JL, Chen W, Wang JL, Tian YP, Gao N, An J. 2008. Rab8, a vesicular traffic regulator, is involved in dengue virus infection in HepG2 cells. Intervirology 51:182-188. http://dx.doi.org/10.1159/000151531.
31. Xu XF, Chen ZT, Gao N, Zhang JL, An J. 2009. Myosin Vc, a member of the actin motor family associated with Rab8, is involved in the release of DV2 from HepG2 cells. Intervirology 52:258-265. http://dx.doi.org/10.1159/000230669.
32. Chan SC, Lo SY, Liou JW, Lin MC, Syu CL, Lai MJ, Chen YC, Li HC. 2011. Visualization of the structures of the hepatitis C virus replication complex. Biochem. Biophys. Res. Commun. 404:574-578. http://dx.doi.org/10.1016/j.bbrc.2010.12.037.
33. Salloum S, Wang H, Ferguson C, Parton RG, Tai AW. 2013. Rab18 binds to hepatitis C virus NS5A and promotes interaction between sites of viral replication and lipid droplets. PLoS Pathog. 9:e1003513. http://dx.doi.org/10.1371/journal.ppat.1003513.
34. Huang JT, Tseng CP, Liao MH, Lu SC, Yeh WZ, Sakamoto N, Chen CM, Cheng JC. 2013. Hepatitis C virus replication is modulated by the interaction of nonstructural protein NS5B and fatty acid synthase. J. Virol. 87:4994-5004. http://dx.doi.org/10.1128/JVI.02526-12.
35. Liu S, Storrie B. 2012. Are Rab proteins the link between Golgi organization and membrane trafficking? Cell. Mol. Life Sci. 69:4093-4106. http://dx.doi.org/10.1007/s00018-012-1021-6.
36. Behnia R, Munro S. 2005. Organelle identity and the signposts for membrane traffic. Nature 438:597-604. http://dx.doi.org/10.1038/nature04397.
37. Yang H, Galea A, Sytnyk V, Crossley M. 2012. Controlling the size of lipid droplets: lipid and protein factors. Curr. Opin. Cell Biol. 24:509-516. http://dx.doi.org/10.1016/j.ceb.2012.05.012.
38. Berger KL, Cooper JD, Heaton NS, Yoon R, Oakland TE, Jordan TX, Mateu G, Grakoui A, Randall G. 2009. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc. Natl. Acad. Sci. U. S. A. 106:7577-7582. http://dx.doi.org/10.1073/pnas.0902693106.
39. Borawski J, Troke P, Puyang X, Gibaja V, Zhao S, Mickanin C, Leighton-Davies J, Wilson CJ, Myer V, Cornellataracido I, Baryza J, Tallarico J, Joberty G, BantscheffM, Schirle M, Bouwmeester T, Mathy JE, Lin K, Compton T, Labow M, Wiedmann B, Gaither LA. 2009. Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication. J. Virol. 83:10058-10074. http://dx.doi.org/10.1128/JVI.02418-08.
40. Trotard M, Lepere-Douard C, Regeard M, Piquet-Pellorce C, Lavillette D, Cosset FL, Gripon P, Le Seyec J. 2009. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening. FASEB J. 23:3780-3789. http://dx.doi.org/10.1096/fj.09-131920.
41. Hsu NY, Ilnytska O, Belov G, Santiana M, Chen YH, Takvorian PM, Pau C, van der Schaar H, Kaushik-Basu N, Balla T, Cameron CE, Ehrenfeld E, van Kuppeveld FJ, Altan-Bonnet N. 2010. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141:799-811. http://dx.doi.org/10.1016/j.cell.2010.03.050.
42. Reiss S, Rebhan I, Backes P, Romero-Brey I, Erfle H, Matula P, Kaderali L, Poenisch M, Blankenburg H, Hiet MS, Longerich T, Diehl S, Ramirez F, Balla T, Rohr K, Kaul A, Buhler S, Pepperkok R, Lengauer T, Albrecht M, Eils R, Schirmacher P, Lohmann V, Bartenschlager R. 2011. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9:32-45. http://dx.doi.org/10.1016/j.chom.2010.12.002.
43. Bianco A, Reghellin V, Donnici L, Fenu S, Alvarez R, Baruffa C, Peri F, Pagani M, Abrignani S, Neddermann P, De Francesco R. 2012. Metabolism of phosphatidylinositol 4-kinase IIIalpha-dependent PI4P is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity. PLoS Pathog. 8:e1002576. http://dx.doi.org/10.1371/journal.ppat.1002576.
44. Lamarche MJ, Borawski J, Bose A, Capacci-Daniel C, Colvin R, Dennehy M, Ding J, Dobler M, Drumm J, Gaither LA, Gao J, Jiang X, Lin K, McKeever U, Puyang X, Raman P, Thohan S, Tommasi R, Wagner K, Xiong X, Zabawa T, Zhu S, Wiedmann B. 2012. Anti-hepatitis C virus activity and toxicity of type III phosphatidylinositol-4-kinase beta inhibitors. Antimicrob. Agents Chemother. 56:5149-5156. http://dx.doi.org/10.1128/AAC.00946-12.